Eosinophilia–myalgia syndrome
(Redirected from Eosinophilia-myalgia syndrome)
Eosinophilia–myalgia syndrome (EMS) is a rare, sometimes fatal neurological condition linked to the ingestion of the dietary supplement L-tryptophan. The syndrome is characterized by elevated levels of eosinophils (a type of white blood cell) in the blood and severe muscle pain (myalgia).
History[edit | edit source]
EMS was first identified in the late 1980s when an outbreak of the syndrome occurred in the United States. The outbreak was traced to the consumption of L-tryptophan supplements, which were later found to be contaminated. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) played crucial roles in identifying and managing the outbreak.
Symptoms[edit | edit source]
The primary symptoms of EMS include:
- Severe muscle pain (myalgia)
- Elevated levels of eosinophils in the blood (eosinophilia)
- Skin changes such as rashes
- Respiratory issues
- Neurological symptoms such as memory loss and difficulty concentrating
Causes[edit | edit source]
The exact cause of EMS is not fully understood, but it is strongly associated with the ingestion of contaminated L-tryptophan supplements. The contaminants in these supplements are believed to trigger an abnormal immune response, leading to the symptoms of EMS.
Diagnosis[edit | edit source]
Diagnosis of EMS is based on clinical symptoms and laboratory findings, including:
- Elevated eosinophil count
- Muscle biopsy showing inflammation
- Exclusion of other conditions that could cause similar symptoms
Treatment[edit | edit source]
There is no specific cure for EMS, and treatment primarily focuses on managing symptoms. Common treatments include:
- Corticosteroids to reduce inflammation
- Pain management strategies
- Physical therapy to maintain muscle function
Prognosis[edit | edit source]
The prognosis for individuals with EMS varies. Some patients recover fully with appropriate treatment, while others may experience chronic symptoms or complications. Early diagnosis and treatment are crucial for improving outcomes.
Prevention[edit | edit source]
The primary prevention strategy for EMS is to avoid the use of L-tryptophan supplements, especially those that are not regulated or tested for purity.
Related Pages[edit | edit source]
- Eosinophil
- Myalgia
- L-tryptophan
- Centers for Disease Control and Prevention
- Food and Drug Administration
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD